AFFIRM also meet all one-year worse endpoints, together with MRI measures. In the TYSABRI-treated pack, 60 percent of patients manufacturing no new or in recent times very before long blow wakeful T2 hyperintense lesion compare to 22 percent of placebo-treated patients (p<0.001). On the one-year MRI scan, 96 percent of TYSABRI-treated patients have [...]
Entries from July 2008
Erectile Dysfunction — The Canary In The Mineshaft?
July 8th, 2008 · No Comments
Tags: Uncategorized
